
ISMP Newsroom
ISMP
Media Inquiries
For media inquiries and interviews with ISMP's subject matter experts, please contact Renee Brehio at rbrehio@ismp.org.
Press Coverage

Blank NMBA Cap Poses Lethal Med Error Risk
This article appeared on the Pharmacy Practice News website on July 6, 2020.
En savoir plusNews

ISMP commends the U.S. Food and Drug Administration for requesting that Pfizer revise its current prescribing information and product packaging for vinCRIStine to eliminate syringe administration.
En savoir plusNews

ISMP Warns about Medication Safety Issues with Drug Shortage Replacement Products
Practitioners should be prepared to take extra precautions with vials of neuromuscular blocking agents without the usual “Warning: Paralyzing Agent” statement required on vial caps and a propofol p...
En savoir plusPress Coverage

This article appeared on the Anesthesia Patient Safety Foundation website on June 5, 2020.
En savoir plusPress Coverage

ISMP Issues Alert on Remdesivir Labeling, Propofol Dosing
This article appeared on the Infectious Disease Special Edition website on May 20, 2020.
En savoir plusPress Coverage

Push Is on to Make IV Workflow Systems Universal
This article appeared on the Pharmacy Practice News website on May 19, 2020.
En savoir plusStay Connected
Get medication safety news, event invitations and updates straight to your inbox!
Social Media
View the Latest from ECRI

HANYS Marketplace® has partnered with ECRI, a nonprofit organization advancing the safety and quality of healthcare, to provide New York’s hospitals and health systems with evidence-based solutions...
En savoir plus
ECRI Names Cottage Health Winner of 2026 Health Technology Excellence Award
Innovative blood management initiative recognized for reducing waste through proactive interfacility transfers. ECRI, a nonprofit organization advancing the safety and quality of healthcare, has ho...
En savoir plus
ECRI & ISMP Statement in Response to PCAC Decision on Compounding Peptides
The FDA Pharmacy Compounding Advisory Committee (PCAC) decided to recommend adding most of the peptides under consideration during its July 23-24, 2026, meeting to the 503A Bulks List, despite subs...
En savoir plus